Predictors of opioid overdose during the COVID-19 pandemic: The role of relapse, treatment access and nonprescribed buprenorphine/naloxone.

J Subst Use Addict Treat · 2023 · PMC10063455 · PMID 37003539

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

An unexpected finding of this study was the highly significant association between nonprescribed buprenorphine/naloxone use and increased overdose risk, countering recent suggestions that nonprescribed use may confer public health benefits when treatment is inaccessible ( Carlson et al., 2020 ; Chilcoat et al., 2019 ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.